TrialScientific reports2025

Levofloxacin for the prevention of febrile episodes in non-Hodgkin lymphoma patients treated with CHOP plus rituximab in a randomized controlled trial.

Mutita Surakijboworn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.